These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect. Barbieri RL; Hornstein MD Endocrinol Metab Clin North Am; 1988 Dec; 17(4):685-703. PubMed ID: 3058472 [TBL] [Abstract][Full Text] [Related]
63. Insulin resistance in obese adolescents. Li HJ; Huang CY; Lee HC; Chen MR; Lo FS; Lin CH; Wang AM; Shih BF; Lee YJ Acta Paediatr Taiwan; 2005; 46(2):61-6. PubMed ID: 16302580 [TBL] [Abstract][Full Text] [Related]
64. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551 [TBL] [Abstract][Full Text] [Related]
65. Ovarian hyperandrogenism is associated with insulin resistance to both peripheral carbohydrate and whole-body protein metabolism in postpubertal young females: a metabolic study. Mauras N; Welch S; Rini A; Haymond MW J Clin Endocrinol Metab; 1998 Jun; 83(6):1900-5. PubMed ID: 9626116 [TBL] [Abstract][Full Text] [Related]
67. Cutaneous Manifestations of Diabetes Mellitus and Prediabetes. Sanches MM; Roda Â; Pimenta R; Filipe PL; Freitas JP Acta Med Port; 2019 Jun; 32(6):459-465. PubMed ID: 31292028 [TBL] [Abstract][Full Text] [Related]
68. Cutaneous manifestations in children with diabetes mellitus and obesity. Baselga Torres E; Torres-Pradilla M Actas Dermosifiliogr; 2014; 105(6):546-57. PubMed ID: 24698434 [TBL] [Abstract][Full Text] [Related]
69. [HAIR-AN syndrome (HyperAndrogenism, Insulin Resistance, Acanthosis Nigricans) in an adolescent with Cohen's syndrome]. Ingletto D; Ruggiero L; De Sanctis V Minerva Pediatr; 2001 Oct; 53(5):493-4. PubMed ID: 11668286 [No Abstract] [Full Text] [Related]
70. The effect of obesity on skin disease and epidermal permeability barrier status in children. Nino M; Franzese A; Ruggiero Perrino N; Balato N Pediatr Dermatol; 2012; 29(5):567-70. PubMed ID: 22471938 [TBL] [Abstract][Full Text] [Related]
71. Evaluation of an ablative and non-ablative laser procedure in the treatment of striae distensae. Güngör S; Sayilgan T; Gökdemir G; Ozcan D Indian J Dermatol Venereol Leprol; 2014; 80(5):409-12. PubMed ID: 25201840 [TBL] [Abstract][Full Text] [Related]
73. Insulin resistance and skin diseases. Napolitano M; Megna M; Monfrecola G ScientificWorldJournal; 2015; 2015():479354. PubMed ID: 25977937 [TBL] [Abstract][Full Text] [Related]
74. Dermatologic signs in patients with eating disorders. Strumia R Am J Clin Dermatol; 2005; 6(3):165-73. PubMed ID: 15943493 [TBL] [Abstract][Full Text] [Related]
75. Relationship between obesity and other risk factors and skin disease among adult Saudi population. Khalil GM; Al Shobaili HA; Alzolibani A; Al Robaee A J Egypt Public Health Assoc; 2011; 86(3-4):56-62. PubMed ID: 21844760 [TBL] [Abstract][Full Text] [Related]
76. Cutaneous manifestations of obesity in Turkish children: A comparative study. Güven M; Anık A; Ünüvar T; İlgün Gürel D; Şendur N Pediatr Dermatol; 2022 Jul; 39(4):513-519. PubMed ID: 35285075 [TBL] [Abstract][Full Text] [Related]
78. A study of androgen and estrogen receptors alpha, beta in skin tags. El Safoury O; Rashid L; Ibrahim M Indian J Dermatol; 2010; 55(1):20-4. PubMed ID: 20418971 [TBL] [Abstract][Full Text] [Related]
79. Miscellaneous dermatoses associated with the aquatic environment. Mandojana RM; Sims JK Clin Dermatol; 1987; 5(3):134-45. PubMed ID: 3311338 [No Abstract] [Full Text] [Related]
80. Comparison of cutaneous manifestations in diabetic and nondiabetic obese patients: A prospective, controlled study. Ozlu E; Uzuncakmak TK; Takır M; Akdeniz N; Karadag AS North Clin Istanb; 2018; 5(2):114-119. PubMed ID: 30374476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]